Lyka Labs Limited to Receive Rs 63 Lakh Claim Amount from Modi Life Care Industries After Appellate Tribunal Order

Lyka Labs Limited to Receive Rs 63 Lakh Claim Amount from Modi Life Care Industries After Appellate Tribunal Order

Lyka Labs Limited to Receive Rs 63 Lakh Claim Amount from Modi Life Care Industries After Appellate Tribunal Order​

Lyka Labs Limited has received an order from the National Company Law Appellate Tribunal regarding a claim against it by Modi Life Care Industries Limited. The company was directed by the tribunal to receive the claim amount of Rs 63,00,000/- within 30 days from the date of the order.

The directive was received by Lyka Labs Limited on June 4, 2026, following proceedings before the National Company Law Appellate Tribunal at its Principal Bench in New Delhi. The matter relates to an appeal filed under Section 61 of the Insolvency and Bankruptcy Code 2016.

As per the order, Lyka Labs Limited is expected to receive Rs 63,00,000/- from Modi Life Care Industries Limited. In terms of the financial impact, the company stated that aside from receiving this amount, there will be no material effect on its financials or operations.

Key details of the tribunal action and financial implications are as follows:

ParticularsDetails
Authority InvolvedNational Company Law Appellate Tribunal, New Delhi, Principal Bench
Claim AmountRs 63,00,000/-
Date of Receipt of Order04.06.2026
Impact on OperationsThe company will receive the full amount as directed by the NCLAT Appellate Tribunal.

LYKALABS Stock Price Movement​

Today, the stock of Lyka Labs Ltd rallied, settling at ₹60.36 after gaining 4.99% in post-market trading. The shares closed near their intraday high, which was recorded at ₹60.36, with a total traded volume of 99,496 shares.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top